Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
NCT02447874
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Sickle Cell Disease
Interventions
DRUG:
Arginine
DRUG:
Arginine (Loading)
DRUG:
Arginine (Continuous)
Sponsor
Emory University
Collaborators
[object Object]
[object Object]